These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3525681)

  • 21. Cold reacting antinuclear antibody in Henoch-Schönlein Purpura.
    Saulsbury FT; Pearl ER
    J Clin Lab Immunol; 1983 Nov; 12(3):123-7. PubMed ID: 6363709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of laboratory tests in the diagnosis of SLE.
    Egner W
    J Clin Pathol; 2000 Jun; 53(6):424-32. PubMed ID: 10911799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on autoantibodies in systemic lupus erythematosus with peroxidase-labeled antibody technic. Ultrastructural localization of the antigens and a test for antinuclear and anticytoplasmic factors].
    Machida M
    Nihon Naika Gakkai Zasshi; 1971 May; 60(5):408-19. PubMed ID: 4939865
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitation in immunofluorescence by radioimmunoassay.
    Johnson GD
    Ann N Y Acad Sci; 1971 Jun; 177():434-8. PubMed ID: 4945675
    [No Abstract]   [Full Text] [Related]  

  • 25. 'In vitro' study of a reaction between the complement system and cellular DNA.
    Peltier AP; Cyna L; Dryll A
    Immunology; 1978 Nov; 35(5):779-84. PubMed ID: 363605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indirect immunofluorescence technique to detect monoclonal antinuclear antibody.
    Johnson TL; Keren DF; Thomas LR
    Arch Pathol Lab Med; 1987 Jun; 111(6):560-2. PubMed ID: 3107515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of specific antineuronal nuclear antibodies in sera of patients with myasthenia gravis. Indirect and direct immunofluorescence.
    Martin L; Herr JC; Wanamaker W; Kornguth S
    Neurology; 1974 Jul; 24(7):680-3. PubMed ID: 4600589
    [No Abstract]   [Full Text] [Related]  

  • 28. The frequency of antinuclear antibody (ANA) in children by use of mouse kidney (MK) and human epithelial cells (HEp-2) as substrates.
    Arroyave CM; Giambrone MJ; Rich KC; Walaszek M
    J Allergy Clin Immunol; 1988 Nov; 82(5 Pt 1):741-4. PubMed ID: 3263996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standardisation of tests for antinuclear antibody.
    Johnson GD; Holborow EJ
    Ann Rheum Dis; 1980 Oct; 39(5):529. PubMed ID: 7002068
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence of positive antinuclear antibodies in healthy children.
    Wananukul S; Voramethkul W; Kaewopas Y; Hanvivatvong O
    Asian Pac J Allergy Immunol; 2005; 23(2-3):153-7. PubMed ID: 16252846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases.
    Prost AC; Abuaf N; Rouquette-Gally AM; Homberg JC; Combrisson A
    Ann Biol Clin (Paris); 1987; 45(6):610-7. PubMed ID: 3326434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinuclear antibodies. I. Patterns of nuclear immunofluorescence.
    Burnham TK; Bank PW
    J Invest Dermatol; 1974 May; 62(5):526-34. PubMed ID: 4595992
    [No Abstract]   [Full Text] [Related]  

  • 33. The Trypanosoma lewisi immunofluorescence test: a new simple technique for simultaneous determination of total antinuclear antibodies and the detection of antibodies to double-stranded DNA.
    Valesini G; Masala C
    J Immunol Methods; 1982; 48(2):177-88. PubMed ID: 7035570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate specificity of antinuclear antibodies in scleroderma.
    Blaszczyk M; Beutner EH; Rogozinski T; Rzesa G; Jarzabek-Chorzelska M; Jablonska S; Chorzelski TP
    J Invest Dermatol; 1977 Apr; 68(4):191-3. PubMed ID: 66298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinuclear antibodies as indicators for the procainamide-induced systemic lupus erythematosus-like syndrome and its clinical presentations.
    Gorsulowsky DC; Bank PW; Goldberg AD; Lee TG; Heinzerling RH; Burnham TK
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):245-53. PubMed ID: 3882781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?--The routine use of anti-nuclear antibody screening ELISAs.
    Sinclair D; Saas M; Williams D; Hart M; Goswami R
    Clin Lab; 2007; 53(3-4):183-91. PubMed ID: 17447656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of passive haemagglutination test and immunofluorescent test for antibody to native deoxyribonucleic acid.
    Niemhom S; Petchclai B; Vanichapuntu M
    J Med Assoc Thai; 1991 Mar; 74(3):145-8. PubMed ID: 1861130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antinuclear antibody determinations in Ro(SSA)-positive, antinuclear antibody--negative lupus and Sjögren's syndrome patients.
    Doré N; Synkowski D; Provost TT
    J Am Acad Dermatol; 1983 May; 8(5):611-5. PubMed ID: 6408145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening tests for antinuclear antibodies (ANA): selective use of central nuclear antigens as a rational basis for screening by ELISA.
    Olaussen E; Rekvig OP
    J Autoimmun; 1999 Aug; 13(1):95-102. PubMed ID: 10441173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinuclear antibodies by indirect immunofluorescence : optimum screening dilution for diagnosis of systemic lupus erythematosus.
    Ghosh P; Dwivedi S; Naik S; Agarwal V; Verma A; Aggarwal A; Misra R
    Indian J Med Res; 2007 Jul; 126(1):34-8. PubMed ID: 17890821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.